SB 483
Referred to committee
Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.
- Michigan
- Senate
- Introduced Sep 12, 2023
- Session 2023-2024
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Michigan’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
13 actions-
referred to Committee on Insurance and Financial Services
-
read a first time
-
received on 10/04/2023
-
PASSED ROLL CALL # 498 YEAS 20 NAYS 17 EXCUSED 0 NOT VOTING 1
-
AMENDMENT(S) DEFEATED
-
AMENDMENT(S) ADOPTED
-
PLACED ON ORDER OF THIRD READING WITH SUBSTITUTE (S-1)
-
SUBSTITUTE (S-1) CONCURRED IN
-
REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE (S-1)
-
REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE (S-1)
-
REPORTED FAVORABLY WITH SUBSTITUTE (S-1)
-
REFERRED TO COMMITTEE ON FINANCE, INSURANCE, AND CONSUMER PROTECTION
-
INTRODUCED BY SENATOR DARRIN CAMILLERI